Literature DB >> 32175733

Rational Substitution of ε-Lysine for α-Lysine Enhances the Cell and Membrane Selectivity of Pore-Forming Melittin.

Venkatesh Mayandi1,2, Qingxiao Xi1, Eunice Tze Leng Goh1, Siew Kwan Koh3, Thomas Yong Jie Toh1, Veluchamy Amutha Barathi1,4,5, Mobashar Hussain Urf Turabe Fazil6, Madhavi Latha Somaraju Chalasani6, Jayasudha Varadarajan1, Darren Shu Jeng Ting1,7, Roger W Beuerman1,5, Lai Wah Chan8, Rupesh Agrawal9, Timothy Mark Sebastian Barkham10, Lei Zhou3,4,5, Navin Kumar Verma1,6,11, Rajamani Lakshminarayanan1,5,8.   

Abstract

Here, we present a rational approach that enhances the membrane selectivity of a prolific pore-forming peptide, melittin, based on experimental observations that the cationic polymer, ε-polylysine, disrupts bacterial membranes with greater affinity over mammalian cells when compared to poly-l-lysine and poly-d-lysine. We systematically replaced three α-lysine residues in melittin with ε-lysine residues and identified key residues that are important for cytotoxicity. We then assessed the antimicrobial properties of the modified peptides which carry two or three ε-lysyl residues. Two modified melittin peptides displayed rapid bactericidal properties against antibiotic-resistant strains, low innate resistance development by pathogenic bacteria, remained nonimmunogenic for T lymphocytes, and increased bioavailability in tear fluids. In proof-of-concept in vivo experiments, one of the peptides was noncytotoxic for ocular surfaces and had comparable antimicrobial efficacy to that of fluoroquinolone antibiotics. The results uncover a simple and potential strategy that can enhance the membrane selectivity of cytolytic peptides by ε-lysylation.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32175733     DOI: 10.1021/acs.jmedchem.9b01846

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

1.  Risk Factors, Clinical Outcomes, and Prognostic Factors of Bacterial Keratitis: The Nottingham Infectious Keratitis Study.

Authors:  Darren Shu Jeng Ting; Jessica Cairns; Bhavesh P Gopal; Charlotte Shan Ho; Lazar Krstic; Ahmad Elsahn; Michelle Lister; Dalia G Said; Harminder S Dua
Journal:  Front Med (Lausanne)       Date:  2021-08-11

Review 2.  Infectious keratitis: an update on epidemiology, causative microorganisms, risk factors, and antimicrobial resistance.

Authors:  Darren Shu Jeng Ting; Charlotte Shan Ho; Rashmi Deshmukh; Dalia G Said; Harminder S Dua
Journal:  Eye (Lond)       Date:  2021-01-07       Impact factor: 3.775

Review 3.  Recent Advances in Epsilon-Poly-L-Lysine and L-Lysine-Based Dendrimer Synthesis, Modification, and Biomedical Applications.

Authors:  Sijin Chen; Shuting Huang; Yan Li; Chuncai Zhou
Journal:  Front Chem       Date:  2021-03-30       Impact factor: 5.221

4.  Clinical Characteristics and Outcomes of Fungal Keratitis in the United Kingdom 2011-2020: A 10-Year Study.

Authors:  Darren Shu Jeng Ting; Mohamed Galal; Bina Kulkarni; Mohamed S Elalfy; Damian Lake; Samer Hamada; Dalia G Said; Harminder S Dua
Journal:  J Fungi (Basel)       Date:  2021-11-12

Review 5.  Host Defense Peptides at the Ocular Surface: Roles in Health and Major Diseases, and Therapeutic Potentials.

Authors:  Darren Shu Jeng Ting; Imran Mohammed; Rajamani Lakshminarayanan; Roger W Beuerman; Harminder S Dua
Journal:  Front Med (Lausanne)       Date:  2022-06-16

6.  Evaluation of Host Defense Peptide (CaD23)-Antibiotic Interaction and Mechanism of Action: Insights From Experimental and Molecular Dynamics Simulations Studies.

Authors:  Darren Shu Jeng Ting; Jianguo Li; Chandra S Verma; Eunice T L Goh; Mario Nubile; Leonardo Mastropasqua; Dalia G Said; Roger W Beuerman; Rajamani Lakshminarayanan; Imran Mohammed; Harminder S Dua
Journal:  Front Pharmacol       Date:  2021-10-07       Impact factor: 5.810

7.  Hybrid derivative of cathelicidin and human beta defensin-2 against Gram-positive bacteria: A novel approach for the treatment of bacterial keratitis.

Authors:  Imran Mohammed; Harminder S Dua; Darren Shu Jeng Ting; Eunice Tze Leng Goh; Venkatesh Mayandi; Joanna M F Busoy; Thet Tun Aung; Mercy Halleluyah Periayah; Mario Nubile; Leonardo Mastropasqua; Dalia G Said; Hla M Htoon; Veluchamy Amutha Barathi; Roger W Beuerman; Rajamani Lakshminarayanan
Journal:  Sci Rep       Date:  2021-09-15       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.